Hints and tips:
Related Special Reports
...This week, his clients Prometheus Biosciences and Bellus Health, announced sales to large pharmaceuticals companies in buyouts in total valued at $13bn....
...L: 7; I: 7; Total: 20The firm advised South Korean pharmaceutical company SD Biosensor and South Korean private equity fund SJL Partners on the acquisition of US-listed pharmaceutical business Meridian Bioscience...
...The ruling could set a significant precedent because it extends Brussels’ reach over deals in sectors such as technology and biosciences that potentially damage European rivals, adding an extra level of...
...Zhao declined to comment. 12) Telis Bioscience ($1mn for 2pc) CEO Grigory Khimulya says Telis Bioscience is “a venture-backed biotech company in Cambridge, MA engineering high-impact protein therapeutics...
...and KeyMed Biosciences....
...Emerald Advisers and Citadel also owned shares in several of the top performers, companies that include Huya, a Chinese online game-streaming platform; the biotech companies AvroBio, Allakos and Solid Biosciences...
...Under its alternative proposal, the specialty products company would have four separate business divisions — electronic specialities; nutrition and biosciences; specialty materials; and silicones — each...
...GV, which invests roughly $500m in high-growth tech companies globally, ws launched in 2009 with a deep tech and biosciences focus....
...BioScience....
...On top of his family foundation’s charitable donations, this year he gave $325m to start the Cohen Veterans Network and Cohen Veterans Bioscience, which help veterans’ mental health and further the science...
...Such links are enhanced by the Oxford Bioscience Network, a not-for-profit group that provides purchasing and networking support for biotech and medical technology companies in Oxford and the south-east....
...Celgene, the US-based biotechnology company, is to buy rival Abraxis BioScience for $2.9bn in cash and stock....
...A sale or float of Organon Biosciences could pave the way for Akzo to launch a bid for ICI, which is valued at £5.5bn, or Sherwin-Williams, the US paint company....
...On Thursday, AstraZeneca said it would pay $200m to Abraxis BioScience, a US company, for the co-marketing rights for Abraxane in the US for an initial five year period, and would also sell its anaesthetics...
...Its loss was modest compared with that of Cypress Bioscience , which tumbled 56.5 per cent to $5.53 in one of the worst showings at the Nasdaq....
International Edition